Covered recipient · General Payments record
ZISANSHA ZAHIRSHA
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2021–2024
$2,492.63
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $911.19 | 3 |
| Food and Beverage | $588.02 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $1,327.56 | 17 |
| Lilly USA, LLC | $54.94 | 3 |
| Amgen Inc. | $48.95 | 2 |
| Kerecis Limited | $25.76 | 1 |
| PFIZER INC. | $14.96 | 1 |
| Galderma Laboratories, L.P. | $13.64 | 1 |
| Arcutis Biotherapeutics, Inc. | $13.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.03 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106387774 | CMS |
| ABBVIE INC. | $30.03 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106387776 | CMS |
| ABBVIE INC. | $68.00 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106387778 | CMS |
| ABBVIE INC. | $252.34 | 02/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106387780 | CMS |
| ABBVIE INC. | $219.62 | 02/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106387782 | CMS |
| ABBVIE INC. | $439.23 | 02/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106387784 | CMS |
| ABBVIE INC. | $6.90 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106387786 | CMS |
| ABBVIE INC. | $35.91 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106387788 | CMS |
| ABBVIE INC. | $47.95 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106387790 | CMS |
| ABBVIE INC. | $80.62 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106387792 | CMS |
| ABBVIE INC. | $25.05 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106387794 | CMS |
| ABBVIE INC. | $12.57 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106387796 | CMS |
| ABBVIE INC. | $23.61 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106387798 | CMS |
| ABBVIE INC. | $12.04 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106387800 | CMS |
| ABBVIE INC. | $9.48 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106387802 | CMS |
| ABBVIE INC. | $14.35 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106387804 | CMS |
| ABBVIE INC. | $19.83 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106387806 | CMS |
| Amgen Inc. | $24.84 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117725006 | CMS |
| Amgen Inc. | $24.11 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117725008 | CMS |
| Arcutis Biotherapeutics, Inc. | $13.40 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121078885 | CMS |
| Galderma Laboratories, L.P. | $13.64 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145337061 | CMS |
| Kerecis Limited | $25.76 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120100497 | CMS |
| Lilly USA, LLC | $18.31 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135508032 | CMS |
| Lilly USA, LLC | $15.91 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135508030 | CMS |
| Lilly USA, LLC | $20.72 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135521239 | CMS |
| PFIZER INC. | $14.96 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131624403 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.